Memobead Technologies provides diagnostics, drug discovery, and forensic technologies.
Within the fields of in vitro diagnostics, ultra high throughput drug screening and forensic applications, Memobead Technologies has the ambition to become a leading provider of randomly usable digitally accurate encoded microcarriers onto which surfaces complex molecular reactions may take place in highly multiplexed fashion.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 1, 2005 | Series Unknown | $720K | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Baekeland Funds | — | Series Unknown |